| Patient | Sugar Ray Robinson |
|---|---|
| Date of birth | 1963-05-03 |
| Identifiers | MRN HR-BX003-SYN; SSN (made up) 000-03-9318 |
| Document date | 2026-07-07 |
| Author | Langston Pryce-Okonjo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety. [S]
White blood cells: 6.4 10*3/uL; Hemoglobin: 14.1 g/dL; Platelets: 231 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1 mg/dL; eGFR (CKD-EPI 2021): 85 mL/min/1.73 m²; Glucose: 126 mg/dL; Hemoglobin A1c: 6.4% (high); Vitamin B12: 352 pg/mL; TSH: 1.9 mIU/L; Urine albumin-to-creatinine ratio: 14 mg/g; MoCA: 18; PHQ-9: 4. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-07 | Body height | 180 | cm | S |
| 2026-07-07 | Body weight | 77 | kg | S |
| 2026-07-07 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 2026-07-07 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-07-07 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-07 | Heart rate | 72 | /min | S |
| 2026-07-07 | Respiratory rate | 14 | /min | S |
| 2026-07-07 | Body temperature | 36.7 | Cel | S |
| 2026-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-07 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-07-07 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-07-07 | Platelets [#/volume] in Blood by Automated count | 231 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-07-07 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-07 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-07 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-07 | Glucose [Mass/volume] in Serum or Plasma | 126 | mg/dL | 70-140 mg/dL | Normal | S |
| 2026-07-07 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.4 | % | <=5.6% | High | S |
| 2026-07-07 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 352 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-07-07 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-07-07 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g | <=29 mg/g | Normal | S |
| 2026-07-07 | Total score [MoCA] | 18 | {score} | S | ||
| 2026-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 2024-03-01 | active | S |
| Glipizide 5 mg oral tablet, one tablet before breakfast | One tablet before breakfast | Oral route | 2025-01-15 to 2026-08-18 | completed | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2023-06-01 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2024-03-01 | active | S |
| Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter | One capsule at bedtime | Oral route | 2025-10-01 to 2026-07-07 | stopped | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found | active | confirmed | R41.3 | S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea | active | confirmed | E11.9 | S — Synthetic modern diabetes anchored to his documented diabetes. |
| Hypertension, controlled on lisinopril | active | confirmed | I10 | S — Synthetic modern hypertension anchored to the single press report. |